ID   KOLF2.1J ATP13A2 c1306 SNV/SNV
AC   CVCL_F2AU
SY   JIPSC003044; ATP13A2 c.1306+5G>A; ATP13A2 c1306 SNV/SNV
WW   Provider; JAX; JIPSC003044; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003044
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:30213; ATP13A2; Simple_edited; c.1306+5G>A; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 31-03-26; Last updated: 31-03-26; Version: 1
//